Digital by design approach to develop a universal deep learning AI architecture for automatic chromatographic peak integration

Author:

Satwekar Abhijeet1ORCID,Panda Anubhab2,Nandula Phani2,Sripada Sriharsha2,Govindaraj Ramachandiran2,Rossi Mara1

Affiliation:

1. Global Analytical – Pharmaceutical Sciences & Innovation, Global Analytical Development, Global CMC Development Merck Serono S.p.A. (Affilitate of Merck KGaA, Darmstadt, Germany) Guidonia Montecelio Rome Italy

2. Bosch Global Software Technologies Private Limited Bangalore India

Abstract

AbstractChromatographic data processing has garnered attention due to multiple Food and Drug Administration 483 citations and warning letters, highlighting the need for a robust technological solution. The healthcare industry has the potential to greatly benefit from the adoption of digital technologies, but the process of implementing these technologies can be slow and complex. This article presents a “Digital by Design” managerial approach, adapted from pharmaceutical quality by design principles, for designing and implementing an artificial intelligence (AI)‐based solution for chromatography peak integration process in the healthcare industry. We report the use of a convolutional neural network model to predict analytical variability for integrating chromatography peaks and propose a potential GxP framework for using AI in the healthcare industry that includes elements on data management, model management, and human‐in‐the‐loop processes. The component on analytical variability prediction has a great potential to enable Industry 4.0 objectives on real‐time release testing, automated quality control, and continuous manufacturing.

Publisher

Wiley

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Reference82 articles.

1. Abood D. Quilligan A. Narsalay R. &Sen A.(2019).How to successfully scale digital innovation to drive growth. Accenture.https://www.accenture.com/in-en/insights/industry-x-0/scaling-digital

2. Amazon Web Services. (2021).GxP systems on AWS.https://docs.aws.amazon.com/whitepapers/latest/gxp-systems-on-aws/gxp-systems-on-aws.html

3. Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future

4. AI and big data will continue to disrupt pharma sector, says survey;Begley A.;European Pharmaceutical Review,2021

5. Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3